REPL vs JNJ: Which Stock is Better?

Side-by-side comparison of Replimune Group Inc and Johnson & Johnson in 2026

Comparison Updated:

REPL

Replimune Group Inc

JNJ

Johnson & Johnson

$241.00

Key Metrics Comparison

MetricREPLJNJWinner
Market Cap$825.73M$375.37BJNJ
P/E RatioN/A17.35JNJ
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze REPL

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is REPL or JNJ a better investment?

Comparing REPL and JNJ: Replimune Group Inc has a market cap of $825.73M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between REPL and JNJ?

REPL (Replimune Group Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: REPL or JNJ?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: REPL or JNJ?

Both REPL and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: REPL or JNJ?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: REPL or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $825.73M for REPL.

Should I buy REPL or JNJ in 2026?

Both REPL and JNJ have investment merit. REPL trades at $N/A while JNJ trades at $241.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between REPL and JNJ stock?

Key differences: Market Cap ($825.73M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy REPL or JNJ in 2026?

The choice between REPL and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between REPL and JNJ?

REPL (Replimune Group Inc) has a market cap of $825.73M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.

Popular Stock Comparisons